Vasundhara Rasayans Hits New 52-Week Low at Rs. 162.2

Vasundhara Rasayans, a microcap company in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a 52-week low of Rs. 162.2 on October 6, 2025. This decline marks a notable underperformance, as the stock has fallen by 7.47% during the trading session, trailing the sector by 2.44%.
Over the past year, Vasundhara Rasayans has experienced a substantial drop of 40.76%, contrasting sharply with the Sensex, which has only declined by 0.32% during the same period. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent downward trend.

Financial metrics reveal a challenging landscape for the company, with a reported net sales figure of Rs. 7.56 crore, the lowest in recent quarters, and a significant decline in profit after tax (PAT) of 65.89% over the last six months. The company's return on equity stands at 11.1%, and it is trading at a premium compared to its peers' historical valuations. As the market continues to evolve, Vasundhara Rasayans faces a critical juncture in its operational trajectory.